PARP1 and in situ carcinoma: It is known that CIS can elicit chemoresistance through hyper activity of PARP-1 in non-small cell lung carcinomas [16] and that PARP-1 regulates EMT through SNAIL expression in doxorubicin-resistant MDA-MB-231 cells [17].